5-HT3 Receptor Antagonists [moft]
treatment [ftcn]
Nausea [sosy]
Vomiting [sosy]
Side Effect [patf]
Profile [lbpr]
Nausea [sosy]
Vomiting [sosy]
Distress [menp]
Discomfort [sosy]
Patients [podg]
Chemotherapy [topp]
radiotherapy [inpr]
Surgery [bmod]
Several [qnco]
Class [inpr]
Antiemetic Agents [phsu]
Exist [cnce]
side effects [ftcn]
5-HT3 Receptor Antagonists [moft]
First-Line Treatment [topp]
choice [inbe]
Cancer Patient [podg]
considered [idcn]
gold standard [qlco]
Anti-emetic [phsu]
therapy [ftcn]
Compared [acty]
Old [tmco]
Generation [tmco]
Antiemetic Drugs [phsu]
5-HT3 Receptor Antagonists [moft]
effective [qlco]
Well [qlco]
Few [qnco]
side effects [ftcn]
Agent [chvf]
Suggest [idcn]
Intensity [qlco]
adverse events [fndg]
Class [inpr]
Side Effect [patf]
Profile [lbpr]
supportive care/therapy [topp]
Certain [qlco]
subgroups [virs]
Patients [podg]
Including [ftcn]
paediatric [bmod]
Patients [podg]
Elderly [popg]
Suffering [mobd]
Co-morbid conditions [fndg]
Cardiovascular disease [dsyn]
Renal [bpoc]
Hepatic impairment [dsyn]
Dolasetron [orch, phsu]
CARDIOVASCULAR [bdsy]
Extreme [qlco]
Patients [podg]
suffer [mobd]
Cardiac conduction [ortf]
intervals [tmco]
Ondansetron [orch, phsu]
Hand [bpoc]
central nervous system effects [ortf]
Side [spco]
Dolasetron [orch, phsu]
Ondansetron [orch, phsu]
Pharmacokinetic Parameters [idcn]
Affected [ftcn]
Patients [podg]
Hepatic impairment [dsyn]
Dose Adjustment [hlca]
clinicians [prog]
Evaluate [ftcn]
Patients [podg]
Basis [ftcn]
choosing [acty]
5-HT3-receptor antagonist [orch, phsu]
